UP!

CEL $0.03

CEL target price
0.03
0
0

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q2 2020 2020-08-17 0.00 -0.09
Q1 2020 2020-05-21 0.00 -0.08
Q4 2019 2020-03-23 0.00 -0.13
Q3 2019 2019-11-27 0.00 -0.01
Q2 2019 2019-08-15 0.00 -0.08
Q1 2019 2019-05-28 0.00 -0.04
Q4 2018 2019-03-18 0.00 -0.08
Q3 2018 2018-11-23 0.00 0.00

Ratings

2009-08-18 Reiterated Jefferies & Co Buy $32 to $34
2009-07-07 Downgrade RBC Capital Mkts Outperform to Sector Perform $32
2009-05-27 Reiterated Jefferies & Co Buy $27 to $32
2009-03-03 Reiterated
2008-07-18 Initiated RBC Capital Mkts Outperform $40
2008-05-15 Upgrade Jefferies & Co Hold to Buy $33 to $40
2008-05-12 Upgrade Lehman Brothers Underweight to Equal-Weight
2008-03-24 Downgrade Jefferies & Co Buy to Hold
2007-12-06 Initiated Lehman Brothers Equal-weight
2007-08-15 Downgrade Deutsche Securities Buy to Hold $25 to $25.50
2007-03-20 Initiated William Blair Mkt Perform
2007-03-19 Initiated Jefferies & Co Buy $21
2007-03-19 Initiated Goldman Sachs Neutral $20
2009-08-18 Reiterated Jefferies & Co Buy $32 to $34
2009-07-07 Downgrade RBC Capital Mkts Outperform to Sector Perform $32
2009-05-27 Reiterated Jefferies & Co Buy $27 to $32
2009-03-03 Reiterated
2008-07-18 Initiated RBC Capital Mkts Outperform $40

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Funds

In CEL 2 funds of 2213 total. Show all

Fund name Ticker shares
Delek Group, Ltd. 2.16M
MetLife Securities, Inc 1313

Major Shareholders

Name Relationship Total Shares Holding stocks